Access the full text.
Sign up today, get DeepDyve free for 14 days.
J. Jasper, A. Kosaka, Z. To, D. Chang, R. Eglen (1997)
Cloning, expression and pharmacology of a truncated splice variant of the human 5‐HT7 receptor (h5‐HT7(b))British Journal of Pharmacology, 122
J. Selkirk, C. Scott, M. Ho, M. Burton, J. Watson, L. Gaster, L. Collin, B. Jones, D. Middlemiss, G. Price (1998)
SB‐224289–a novel selective (human) 5‐HT1B receptor antagonist with negative intrinsic activityBritish Journal of Pharmacology, 125
(1995)
Pharmacological characterisation of [35S]-GTPgS
T. Lovenberg, B. Baron, L. Lecea, Joseph Miller, R. Prosser, M. Rea, P. Foye, Margaret Racke, Amy Slone, B. Siegel, P. Danielson, J. Sutcliffe, M. Erlander (1993)
A novel adenylyl cyclase-activating serotonin receptor (5-HT7) implicated in the regulation of mammalian circadian rhythmsNeuron, 11
Yung‐chi Cheng, W. Prusoff (1973)
Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.Biochemical pharmacology, 22 23
R. Westphal, E. sanders-Bush (1994)
Reciprocal binding properties of 5-hydroxytryptamine type 2C receptor agonists and inverse agonists.Molecular pharmacology, 46 5
I. Forbes (1998)
(R)‐3,N‐Dimethyl‐N‐ [1‐methyl‐3‐(4‐methylpiperidin‐1‐yl)propyl]benzenesulfonamide: The First Selective 5‐HT7 Receptor Antagonist.ChemInform, 29
D. Thomas, S. Faruq, J. Balcarek, A. Brown (1995)
Pharmacological characterisation of [35S]-GTPgammaS binding to Chinese hamster ovary cell membranes stably expressing cloned human 5-HT1D receptor subtypes.Journal of receptor and signal transduction research, 15 1-4
Y. Salomon (1979)
Adenylate cyclase assay.Advances in cyclic nucleotide research, 10
(1997)
SB - 224289 - a selective h 5 - HT 1 B receptor antagonist with negative intrinsic activity
B. Roth, S. Craigo, M. Choudhary, A. Uluer, F. Monsma, Y. Shen, H. Meltzer, D. Sibley (1994)
Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors.The Journal of pharmacology and experimental therapeutics, 268 3
E. Barker, R. Westphal, D. Schmidt, E. sanders-Bush (1994)
Constitutively active 5-hydroxytryptamine2C receptors reveal novel inverse agonist activity of receptor ligands.The Journal of biological chemistry, 269 16
R. Eglen, Jeffrey Jasper, David Chang, Graeme Martin (1997)
The 5-HT7 receptor: orphan found.Trends in pharmacological sciences, 18 4
P. Hutson, L. Bristow, L. Thorn, M. Tricklebank (1991)
R‐(+)‐HA‐966, a glycine/NMDA receptor antagonist, selectively blocks the activation of the mesolimbic dopamine system by amphetamineBritish Journal of Pharmacology, 103
M. Ruat, E. Traiffort, R. Leurs, J. Tardivel-Lacombe, J. Diaz, J. Arrang, J. Schwartz (1993)
Molecular cloning, characterization, and localization of a high-affinity serotonin receptor (5-HT7) activating cAMP formation.Proceedings of the National Academy of Sciences of the United States of America, 90 18
A. Tsou, A. Kosaka, C. Bach, P. Zuppan, C. Yee, Leonard Tom, R. Alvarez, Scott Ramsey, D. Bonhaus, E. Stefanich, L. Jakeman, R. Eglen, H. Chan (1994)
Cloning and Expression of a 5‐Hydroxytryptamine7 Receptor Positively Coupled to Adenylyl CyclaseJournal of Neurochemistry, 63
N. Stam, Carolien Roesink, F. Dijcks, A. Garritsen, Anne Herpen, W. Olijve (1997)
Human serotonin 5‐HT7 receptor: cloning and pharmacological characterisation of two receptor variantsFEBS Letters, 413
J. Bard, J. Zgombick, N. Adham, P. Vaysse, T. Branchek, R. Weinshank (1993)
Cloning of a novel human serotonin receptor (5-HT7) positively linked to adenylate cyclase.The Journal of biological chemistry, 268 31
A. Sleight, C. Carolo, N. Petit, C. Zwingelstein, A. Bourson (1995)
Identification of 5-hydroxytryptamine7 receptor binding sites in rat hypothalamus: sensitivity to chronic antidepressant treatment.Molecular pharmacology, 47 1
(1996)
High speci ® c activity [ 3 H ] - 5 - CT binding : correlation of guinea - pig cortex with human cloned 5 - HT 7 receptors
D. Hoyer, D. Clarke, J. Fozard, P. Hartig, G. Martin, E. Mylecharane, P. Saxena, P. Humphrey (1994)
International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin).Pharmacological reviews, 46 2
(1995)
Identi ® cation of 5 - HT 7 receptor binding sites in rat hypothalamus
(1995)
Characterisation and distribution of putative 5 - ht 7 receptors in guinea - pig brain
I. Forbes, S. Dabbs, D. Duckworth, Jennings Aj, F. King, P. Lovell, A. Brown, Collin Ll, J. Hagan, D. Middlemiss, G. Riley, David Thomas, N. Upton (1998)
(R)-3,N-dimethyl-N-[1-methyl-3-(4-methyl-piperidin-1-yl) propyl]benzenesulfonamide: the first selective 5-HT7 receptor antagonist.Journal of medicinal chemistry, 41 5
P. Leff (1995)
The two-state model of receptor activation.Trends in pharmacological sciences, 16 3
Arunlakshana (1959)
Some quantitative uses of drug antagonistsBr. J. Pharmacol. Chemother., 14
G. Baxter, N. Tilford (1995)
Endogenous ligands and inverse agonism.Trends in pharmacological sciences, 16 8
A. Newman-Tancredi, C. Conte, C. Chaput, M. Spedding, M. Millan (1997)
Inhibition of the constitutive activity of human 5‐HT1A receptors by the inverse agonist, spiperone but not the neutral antagonist, WAY 100,635British Journal of Pharmacology, 120
P. Schoeffter, Christoph Ullmer, I. Bobirnac, G. Gabbiani, Hermann Lübbert (1996)
Functional, endogenously expressed 5‐hydroxytryptamine 5‐ht7 receptors in human vascular smooth muscle cellsBritish Journal of Pharmacology, 117
Pharmacological characterisation of [ 35 S ] - GTP g S binding to chinese hamster ovary cells membranes stably expressing cloned human 5 - HT 1 D receptor subtypes
T. Kenakin (1996)
The classification of seven transmembrane receptors in recombinant expression systems.Pharmacological reviews, 48 3
D. Thomas, T. Gager, V. Holland, A. Brown, M. Wood (1996)
m-Chlorophenylpiperazine (mCPP) is an antagonist at the cloned human 5-HT2B receptor.Neuroreport, 7 9
(1995)
Characterisation of [35S]-GTPgS binding to CHO cell membranes expressing human 5-HT1Da receptors: Evidence for negative ecacy of 5-HT receptor antagonists
Z. To, D. Bonhaus, R. Eglen, L. Jakeman (1995)
Characterization and distribution of putative 5‐ht7 receptors in guinea‐pig brainBritish Journal of Pharmacology, 115
J. Plassat, N. Amlaiky, R. Hen (1993)
Molecular cloning of a mammalian serotonin receptor that activates adenylate cyclase.Molecular pharmacology, 44 2
O. Arunlakshana, Schild Ho (1997)
SOME QUANTITATIVE USES OF DRUG ANTAGONISTSBritish Journal of Pharmacology, 120
W. Bowen, J. Jerman (1995)
Nonlinear regression using spreadsheets.Trends in pharmacological sciences, 16 12
D. Heidmann, M. Metcalf, R. Kohen, M. Hamblin (1997)
Four 5‐Hydroxytryptamine7 (5‐HT7) Receptor Isoforms in Human and Rat Produced by Alternative Splicing: Species Differences Due to Altered Intron‐Exon OrganizationJournal of Neurochemistry, 68
1 The functional profile of the long form of the human cloned 5‐HT7 receptor (designated h5‐HT7(a)) was investigated using a number of 5‐HT receptor agonists and antagonists and compared with its binding profile. Receptor function was measured using adenylyl cyclase activity in washed membranes from HEK293 cells stably expressing the recombinant h5‐HT7(a) receptor. 2 The receptor binding profile, determined by competition with [3H]‐5‐CT, was consistent with that previously reported for the h5‐HT7(a) receptor. The selective 5‐HT7 receptor antagonist SB‐258719 ((R)‐3,N‐Dimethyl‐N‐[1‐methyl‐3‐(4‐methylpiperidin‐1‐yl)propyl]benzene sulfonamide) displayed high affinity (pKi 7.5) for the receptor. 3 In the adenylyl cyclase functional assay, 5‐CT and 8‐OH‐DPAT were both full agonists compared to 5‐HT and the rank order of potency for agonists (5‐CT>5‐HT>8‐OH‐DPAT) was the same in functional and binding studies. 4 Risperidone, methiothepin, mesulergine, clozapine, olanzapine, ketanserin and SB‐258719 antagonised surmountably 5‐CT‐stimulated adenylyl cyclase activity. Schild analysis of the antagonism by SB‐258719 gave a pA2 of 7.2±0.2 and slope not significantly different from 1, consistent with competitive antagonism. 5 The same antagonists also inhibited basal adenylyl cyclase activity with a rank order of potency in agreement with those for antagonist potency and binding affinity. Both SB‐258719 and mesulergine displayed apparent partial inverse agonist profiles compared to the other antagonists tested. These inhibitory effects of antagonists appear to be 5‐HT7 receptor‐mediated and to reflect inverse agonism. 6 It is concluded that in this expression system, the h5‐HT7(a) receptor shows the expected binding and functional profile and displays constitutive activity, revealing inverse agonist activity for a range of antagonists.
British Journal of Pharmacology – Wiley
Published: Jul 1, 1998
Keywords: ; ; ; ; ; ; ;
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.